| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Wave Life Sciences Ltd. | Chief Medical Officer, Head of Therapeutics Discovery and Development | Share Option (right to buy) | 60,000 | 25 Jul 2022 | Direct | ||
| Athira Pharma, Inc. | Director | Stock Option (Right to Buy) | 20,900 | 30 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 17:36 |
| ATHA | Athira Pharma, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 18:56 |
| ATHA | Athira Pharma, Inc. | 19 May 2023 | 1 | $0 | 4 | Director | 22 May 2023, 18:01 |
| WVE | Wave Life Sciences Ltd. | 25 Jul 2022 | 1 | $0 | 4 | Chief Medical Officer, Head of Therapeutics Discovery and Development | 27 Jul 2022, 21:05 |
| ATHA | Athira Pharma, Inc. | 20 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 17:38 |
| WVE | Wave Life Sciences Ltd. | 04 May 2022 | 2 | -$28,748 | 4 | Chief Medical Officer, Head of Therapeutics Discovery and Development | 06 May 2022, 19:05 |
| ATHA | Athira Pharma, Inc. | 18 Mar 2022 | 1 | $0 | 4 | Director | 21 Mar 2022, 16:40 |
| ATHA | Athira Pharma, Inc. | 18 Mar 2022 | 0 | $0 | 3 | Director | 21 Mar 2022, 16:36 |
| WVE | Wave Life Sciences Ltd. | 16 Feb 2022 | 1 | -$24,493 | 4 | Chief Medical Officer, Head of Therapeutics Discovery and Development | 18 Feb 2022, 17:00 |
| WVE | Wave Life Sciences Ltd. | 01 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer, Head of Therapeutics Discovery and Development | 04 Jan 2022, 20:18 |